Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

Peer Review reports

Original Submission
3 May 2022	Submitted	Original manuscript
10 Jun 2022	Reviewed	Reviewer Report
10 Jun 2022	Reviewed	Reviewer Report
13 Jun 2022	Reviewed	Reviewer Report
10 Jul 2022	Author responded	Author comments - Greta Sommerhäuser
Resubmission - Version 2
10 Jul 2022	Submitted	Manuscript version 2
Publishing
13 Jul 2022	Editorially accepted
27 Jul 2022	Article published	10.1186/s12885-022-09892-8

Back to article page